MBX Biosciences, Inc. (MBX)
28.75
+0.07
(+0.24%)
USD |
NASDAQ |
Dec 10, 12:44
MBX Biosciences EPS Diluted (Quarterly): -0.6321 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| Merck & Co., Inc. | 2.316 |
| Madrigal Pharmaceuticals, Inc. | -5.079 |
| Insmed, Inc. | -1.747 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.62M |
| Total Expenses (Quarterly) | 21.62M |
| Enterprise Value | 572.43M |
| Earnings Yield | -8.33% |
| Normalized Earnings Yield | -8.325 |